Roivant Sciences (NASDAQ:ROIV) Upgraded to Strong-Buy at Cantor Fitzgerald
Cantor Fitzgerald upgraded shares of Roivant Sciences (NASDAQ:ROIV – Free Report) to a strong-buy rating in a report issued on Tuesday,Zacks.com reports. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $18.00 target price on shares of Roivant Sciences in a research report on Tuesday, February 11th. One research analyst has rated the stock […]
Cantor Fitzgerald upgraded shares of Roivant Sciences (NASDAQ:ROIV – Free Report) to a strong-buy rating in a report issued on Tuesday,Zacks.com reports. Separately, HC Wainwright reaffirmed a “buy” rating and issued a $18.00 target price on shares of Roivant Sciences in a research report on Tuesday, February 11th. One research analyst has rated the stock […]
